Kaye, KS, Pogue, JM, Tran, TB, Nation, RL, Li, J. Agents of last resort: polymyxin resistance. Infect Dis Clin N Am 2016;30:391–414.
Monaco, M, Giani, T, Raffone, M, et al. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill 2014;19(42). pii: 20939.
Gao, R, Hu, Y, Li, Z, et al. Dissemination and mechanism for the mcr-1 colistin resistance. PLoS Pathog 2016;12(11):e1005957.
Liu, YY, Wang, Y, Walsh, TR, et al. Emergence of plasmid-mediated colistin resistance mechanism mcr-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 2016;16:161–168.
5.Alert to US healthcare facilities: first mcr-1 gene in E. coli bacteria found in a human in the United States. Centers for Disease Control and Prevention website. https://emergencycdcgov/han/han00390asp. Accessed April 12, 2019.
Skov, RL, Monnet, DL. Plasmid-mediated colistin resistance (mcr-1 gene): three months later, the story unfolds. Euro Surveill 2016;21:30155.10.2807/1560-7917.ES.2016.21.9.30155
Marchaim, D, Chopra, T, Bhargava, A, et al. Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship. Infect Control Hosp Epidemiol 2012;33:817–830.10.1086/666642
McGann, P, Snesrud, E, Maybank, R, et al.
Escherichia coli harboring mcr-1 and blaCTX-M on a novel IncF plasmid: first report of mcr-1 in the United States. Antimicrob Agents Chemother 2016;60:4420–4421.
Arcilla, MS, van Hattem, JM, Matamoros, S, et al. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis 2016;16:147–149.